FRIEDREICH ATAXIA

Clinical trials for FRIEDREICH ATAXIA explained in plain language.

Never miss a new study

Get alerted when new FRIEDREICH ATAXIA trials appear

Sign up with your email to follow new studies for FRIEDREICH ATAXIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 9 Not yet finished but already full! 4 Completed 5 Terminated 1

Early-Stage trial for Friedreich's ataxia drug in kids halted

Disease control Terminated

This early-stage study aimed to check the safety of a drug called nomlabofusp in 18 children and teenagers (ages 2 to 17) with Friedreich's ataxia, a rare genetic disease that affects movement and heart function. The drug was given as a shot under the skin. The study was stopped …

Matched conditions: FRIEDREICH ATAXIA

Phase: PHASE1 • Sponsor: Larimar Therapeutics, Inc. • Aim: Disease control

Last updated May 15, 2026 11:55 UTC

FRIEDREICH ATAXIA

Get alerted when new FRIEDREICH ATAXIA trials appear

Early-Stage trial for Friedreich's ataxia drug in kids halted